Russian Federation

Russian Federation

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.6 (0.54 - 0.67) 2019 Modelled IHME
0.63 (0.56 - 0.69) 2018 Modelled IHME
0.65 (0.57 - 0.72) 2017 Modelled IHME
0.66 (0.59 - 0.74) 2016 Modelled IHME
0.68 (0.61 - 0.75) 2015 Modelled IHME
0.71 (0.64 - 0.78) 2014 Modelled IHME
0.75 (0.67 - 0.82) 2013 Modelled IHME
0.78 (0.70 - 0.87) 2012 Modelled IHME
0.82 (0.73 - 0.91) 2011 Modelled IHME
0.85 (0.75 - 0.94) 2010 Modelled IHME
0.87 (0.78 - 0.97) 2009 Modelled IHME
0.89 (0.80 - 0.99) 2008 Modelled IHME
0.91 (0.81 - 1.02) 2007 Modelled IHME
0.93 (0.83 - 1.04) 2006 Modelled IHME
0.94 (0.84 - 1.05) 2005 Modelled IHME
0.95 (0.84 - 1.06) 2004 Modelled IHME
0.96 (0.85 - 1.07) 2003 Modelled IHME
0.97 (0.86 - 1.08) 2002 Modelled IHME
0.97 (0.86 - 1.08) 2001 Modelled IHME
0.97 (0.86 - 1.09) 2000 Modelled IHME
0.97 (0.86 - 1.08) 1999 Modelled IHME
0.96 (0.85 - 1.07) 1998 Modelled IHME
0.95 (0.85 - 1.06) 1997 Modelled IHME
0.95 (0.83 - 1.05) 1996 Modelled IHME
0.94 (0.83 - 1.05) 1995 Modelled IHME
0.93 (0.82 - 1.04) 1994 Modelled IHME
0.93 (0.82 - 1.04) 1993 Modelled IHME
0.93 (0.81 - 1.04) 1992 Modelled IHME
0.92 (0.81 - 1.04) 1991 Modelled IHME
0.92 (0.81 - 1.04) 1990 Modelled IHME
2.85 (2.27 - 3.53) 2015 Modelled WHO
1.4 (0.60 - 1.70) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.03 (0.03 - 0.04) 2019 Modelled IHME
0.04 (0.03 - 0.04) 2018 Modelled IHME
0.04 (0.03 - 0.04) 2017 Modelled IHME
0.03 (0.03 - 0.04) 2016 Modelled IHME
0.03 (0.03 - 0.04) 2015 Modelled IHME
0.03 (0.03 - 0.04) 2014 Modelled IHME
0.03 (0.03 - 0.04) 2013 Modelled IHME
0.04 (0.03 - 0.04) 2012 Modelled IHME
0.04 (0.03 - 0.04) 2011 Modelled IHME
0.04 (0.03 - 0.05) 2010 Modelled IHME
0.04 (0.03 - 0.05) 2009 Modelled IHME
0.04 (0.04 - 0.05) 2008 Modelled IHME
0.05 (0.04 - 0.06) 2007 Modelled IHME
0.05 (0.04 - 0.06) 2006 Modelled IHME
0.06 (0.05 - 0.07) 2005 Modelled IHME
0.12 (0.09 - 0.14) 2004 Modelled IHME
0.24 (0.19 - 0.28) 2003 Modelled IHME
0.38 (0.31 - 0.45) 2002 Modelled IHME
0.52 (0.42 - 0.61) 2001 Modelled IHME
0.61 (0.50 - 0.72) 2000 Modelled IHME
0.66 (0.54 - 0.79) 1999 Modelled IHME
0.71 (0.58 - 0.85) 1998 Modelled IHME
0.75 (0.61 - 0.89) 1997 Modelled IHME
0.77 (0.63 - 0.92) 1996 Modelled IHME
0.78 (0.64 - 0.93) 1995 Modelled IHME
0.78 (0.64 - 0.93) 1994 Modelled IHME
0.78 (0.64 - 0.93) 1993 Modelled IHME
0.78 (0.64 - 0.92) 1992 Modelled IHME
0.77 (0.62 - 0.91) 1991 Modelled IHME
0.75 (0.61 - 0.89) 1990 Modelled IHME
0.88 (0.58 - 1.26) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
1,388,230 (1,217,710 - 1,573,070) 1990 Modelled IHME
1,396,720 (1,226,000 - 1,578,540) 1991 Modelled IHME
1,404,150 (1,233,580 - 1,581,870) 1992 Modelled IHME
1,409,240 (1,238,410 - 1,582,090) 1993 Modelled IHME
1,412,590 (1,244,750 - 1,580,330) 1994 Modelled IHME
1,415,980 (1,246,260 - 1,577,980) 1995 Modelled IHME
1,423,100 (1,256,900 - 1,580,970) 1996 Modelled IHME
1,434,560 (1,270,150 - 1,594,470) 1997 Modelled IHME
1,446,320 (1,281,260 - 1,609,790) 1998 Modelled IHME
1,453,580 (1,285,890 - 1,619,750) 1999 Modelled IHME
1,453,100 (1,282,950 - 1,619,120) 2000 Modelled IHME
1,445,700 (1,278,000 - 1,611,960) 2001 Modelled IHME
1,434,260 (1,267,730 - 1,598,440) 2002 Modelled IHME
1,419,600 (1,254,620 - 1,581,260) 2003 Modelled IHME
1,402,760 (1,241,490 - 1,561,610) 2004 Modelled IHME
1,384,180 (1,226,600 - 1,540,200) 2005 Modelled IHME
1,361,410 (1,207,580 - 1,514,960) 2006 Modelled IHME
1,333,230 (1,182,790 - 1,483,970) 2007 Modelled IHME
1,300,820 (1,158,250 - 1,445,280) 2008 Modelled IHME
1,265,790 (1,127,460 - 1,406,760) 2009 Modelled IHME
1,229,890 (1,096,340 - 1,366,220) 2010 Modelled IHME
1,188,620 (1,061,040 - 1,316,520) 2011 Modelled IHME
1,140,000 (1,019,500 - 1,259,880) 2012 Modelled IHME
1,088,970 (975,407 - 1,199,790) 2013 Modelled IHME
1,040,940 (930,802 - 1,146,200) 2014 Modelled IHME
1,001,620 (894,324 - 1,103,630) 2015 Modelled IHME
972,858 (868,013 - 1,076,790) 2016 Modelled IHME
946,376 (841,417 - 1,050,230) 2017 Modelled IHME
917,086 (814,896 - 1,017,180) 2018 Modelled IHME
886,282 (790,304 - 982,544) 2019 Modelled IHME
1,947,000 (893,000 - 2,393,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
4.84 (3.90 - 5.90) 2019 Modelled IHME
4.85 (4.06 - 5.63) 2018 Modelled IHME
4.94 (4.26 - 5.71) 2017 Modelled IHME
5.32 (4.59 - 6.13) 2016 Modelled IHME
5.5 (4.75 - 6.35) 2015 Modelled IHME
5.86 (5.05 - 6.77) 2014 Modelled IHME
6.21 (5.36 - 7.14) 2013 Modelled IHME
6.87 (5.94 - 7.92) 2012 Modelled IHME
7.53 (6.52 - 8.68) 2011 Modelled IHME
8.32 (7.19 - 9.58) 2010 Modelled IHME
8.16 (7.10 - 9.36) 2009 Modelled IHME
8.49 (7.41 - 9.73) 2008 Modelled IHME
8.21 (7.22 - 9.38) 2007 Modelled IHME
8.42 (7.39 - 9.61) 2006 Modelled IHME
8.85 (7.78 - 10.10) 2005 Modelled IHME
7.85 (6.90 - 8.95) 2004 Modelled IHME
7.41 (6.51 - 8.44) 2003 Modelled IHME
6.66 (5.86 - 7.59) 2002 Modelled IHME
5.95 (5.26 - 6.76) 2001 Modelled IHME
5.42 (4.80 - 6.15) 2000 Modelled IHME
4.82 (4.26 - 5.47) 1999 Modelled IHME
4.26 (3.73 - 4.87) 1998 Modelled IHME
4.28 (3.76 - 4.88) 1997 Modelled IHME
4.59 (4.06 - 5.21) 1996 Modelled IHME
4.91 (4.32 - 5.59) 1995 Modelled IHME
4.93 (4.28 - 5.67) 1994 Modelled IHME
4.2 (3.71 - 4.80) 1993 Modelled IHME
3.3 (2.90 - 3.74) 1992 Modelled IHME
2.93 (2.57 - 3.33) 1991 Modelled IHME
2.82 (2.48 - 3.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
7,098 (5,727 - 8,653) 2019 Modelled IHME
7,108 (5,952 - 8,254) 2018 Modelled IHME
7,240 (6,250 - 8,369) 2017 Modelled IHME
7,785 (6,726 - 8,982) 2016 Modelled IHME
8,042 (6,941 - 9,288) 2015 Modelled IHME
8,560 (7,380 - 9,888) 2014 Modelled IHME
9,048 (7,814 - 10,414) 2013 Modelled IHME
10,004 (8,646 - 11,528) 2012 Modelled IHME
10,958 (9,483 - 12,623) 2011 Modelled IHME
12,091 (10,449 - 13,935) 2010 Modelled IHME
11,873 (10,320 - 13,613) 2009 Modelled IHME
12,362 (10,790 - 14,160) 2008 Modelled IHME
11,971 (10,522 - 13,672) 2007 Modelled IHME
12,296 (10,797 - 14,029) 2006 Modelled IHME
12,971 (11,399 - 14,800) 2005 Modelled IHME
11,543 (10,149 - 13,160) 2004 Modelled IHME
10,933 (9,615 - 12,457) 2003 Modelled IHME
9,858 (8,673 - 11,241) 2002 Modelled IHME
8,842 (7,811 - 10,051) 2001 Modelled IHME
8,075 (7,154 - 9,170) 2000 Modelled IHME
7,210 (6,376 - 8,176) 1999 Modelled IHME
6,394 (5,600 - 7,311) 1998 Modelled IHME
6,432 (5,648 - 7,331) 1997 Modelled IHME
6,912 (6,108 - 7,846) 1996 Modelled IHME
7,404 (6,512 - 8,437) 1995 Modelled IHME
7,463 (6,477 - 8,574) 1994 Modelled IHME
6,373 (5,621 - 7,276) 1993 Modelled IHME
5,010 (4,409 - 5,681) 1992 Modelled IHME
4,437 (3,901 - 5,051) 1991 Modelled IHME
4,262 (3,750 - 4,836) 1990 Modelled IHME
20,268 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
22 (19 - 26) 2019 Modelled IHME
22 (19 - 26) 2018 Modelled IHME
22 (19 - 26) 2017 Modelled IHME
22 (19 - 26) 2016 Modelled IHME
22 (19 - 26) 2015 Modelled IHME
23 (19 - 27) 2014 Modelled IHME
23 (20 - 27) 2013 Modelled IHME
23 (20 - 27) 2012 Modelled IHME
24 (20 - 27) 2011 Modelled IHME
24 (20 - 28) 2010 Modelled IHME
24 (20 - 28) 2009 Modelled IHME
24 (21 - 28) 2008 Modelled IHME
24 (20 - 27) 2007 Modelled IHME
24 (21 - 28) 2006 Modelled IHME
24 (21 - 28) 2005 Modelled IHME
24 (21 - 28) 2004 Modelled IHME
24 (21 - 28) 2003 Modelled IHME
24 (21 - 28) 2002 Modelled IHME
24 (21 - 28) 2001 Modelled IHME
25 (21 - 29) 2000 Modelled IHME
25 (22 - 29) 1999 Modelled IHME
25 (22 - 29) 1998 Modelled IHME
25 (22 - 30) 1997 Modelled IHME
26 (22 - 30) 1996 Modelled IHME
26 (23 - 31) 1995 Modelled IHME
27 (23 - 31) 1994 Modelled IHME
27 (23 - 31) 1993 Modelled IHME
26 (23 - 31) 1992 Modelled IHME
26 (23 - 31) 1991 Modelled IHME
26 (23 - 31) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
97 2017 Survey/reported WHO/UNICEF
97 2016 Survey/reported WHO/UNICEF
97 2015 Survey/reported WHO/UNICEF
97 2014 Survey/reported WHO/UNICEF
97 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
97 2011 Survey/reported WHO/UNICEF
97 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
98 2008 Survey/reported WHO/UNICEF
98 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
97 2005 Survey/reported WHO/UNICEF
96 2004 Survey/reported WHO/UNICEF
94 2003 Survey/reported WHO/UNICEF
81 2002 Survey/reported WHO/UNICEF
43 2001 Survey/reported WHO/UNICEF
97 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
2 (1 - 3) 2016 Survey/reported Barska G and Sazanov JA, 2016.
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
HepB birth dose policy
Yes
Year of birth dose introduction
2000
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.19 (1.76 - 2.70) 2019 Modelled IHME
2.19 (1.76 - 2.69) 2018 Modelled IHME
2.18 (1.76 - 2.69) 2017 Modelled IHME
2.17 (1.76 - 2.67) 2016 Modelled IHME
2.17 (1.76 - 2.66) 2015 Modelled IHME
2.17 (1.76 - 2.66) 2014 Modelled IHME
2.18 (1.76 - 2.68) 2013 Modelled IHME
2.18 (1.76 - 2.70) 2012 Modelled IHME
2.19 (1.77 - 2.71) 2011 Modelled IHME
2.19 (1.77 - 2.72) 2010 Modelled IHME
2.19 (1.76 - 2.71) 2009 Modelled IHME
2.17 (1.75 - 2.69) 2008 Modelled IHME
2.15 (1.73 - 2.66) 2007 Modelled IHME
2.12 (1.70 - 2.63) 2006 Modelled IHME
2.09 (1.68 - 2.60) 2005 Modelled IHME
2.06 (1.65 - 2.56) 2004 Modelled IHME
2.02 (1.62 - 2.51) 2003 Modelled IHME
1.97 (1.58 - 2.45) 2002 Modelled IHME
1.92 (1.54 - 2.39) 2001 Modelled IHME
1.88 (1.51 - 2.33) 2000 Modelled IHME
1.84 (1.47 - 2.28) 1999 Modelled IHME
1.79 (1.44 - 2.23) 1998 Modelled IHME
1.75 (1.40 - 2.18) 1997 Modelled IHME
1.72 (1.37 - 2.14) 1996 Modelled IHME
1.69 (1.35 - 2.11) 1995 Modelled IHME
1.68 (1.34 - 2.09) 1994 Modelled IHME
1.66 (1.33 - 2.08) 1993 Modelled IHME
1.65 (1.31 - 2.07) 1992 Modelled IHME
1.64 (1.31 - 2.06) 1991 Modelled IHME
1.64 (1.31 - 2.05) 1990 Modelled IHME
3.3 (2.30 - 3.50) 2015 Modelled Blach et al, 2017
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
4.1 (1.20 - 5.60) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
68.7 (59.60 - 77.90) 2012 Modelled Degenhardt L et al, 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
2,474,590 (1,973,270 - 3,095,700) 1990 Modelled IHME
2,486,990 (1,982,290 - 3,116,090) 1991 Modelled IHME
2,502,990 (1,995,310 - 3,137,120) 1992 Modelled IHME
2,519,010 (2,013,280 - 3,150,730) 1993 Modelled IHME
2,534,720 (2,025,110 - 3,158,390) 1994 Modelled IHME
2,551,920 (2,041,710 - 3,187,790) 1995 Modelled IHME
2,581,740 (2,067,270 - 3,222,440) 1996 Modelled IHME
2,630,110 (2,107,020 - 3,278,280) 1997 Modelled IHME
2,689,000 (2,154,750 - 3,346,710) 1998 Modelled IHME
2,748,920 (2,205,000 - 3,413,210) 1999 Modelled IHME
2,803,140 (2,247,270 - 3,473,190) 2000 Modelled IHME
2,857,980 (2,292,750 - 3,545,840) 2001 Modelled IHME
2,918,460 (2,344,600 - 3,625,510) 2002 Modelled IHME
2,977,780 (2,389,240 - 3,697,520) 2003 Modelled IHME
3,029,710 (2,430,620 - 3,760,800) 2004 Modelled IHME
3,066,850 (2,460,850 - 3,806,060) 2005 Modelled IHME
3,096,820 (2,487,000 - 3,843,530) 2006 Modelled IHME
3,129,760 (2,514,840 - 3,879,190) 2007 Modelled IHME
3,159,520 (2,542,170 - 3,915,340) 2008 Modelled IHME
3,180,810 (2,561,670 - 3,937,030) 2009 Modelled IHME
3,188,690 (2,569,700 - 3,948,990) 2010 Modelled IHME
3,185,910 (2,570,740 - 3,942,380) 2011 Modelled IHME
3,180,710 (2,568,880 - 3,925,440) 2012 Modelled IHME
3,174,680 (2,564,500 - 3,904,580) 2013 Modelled IHME
3,170,360 (2,568,010 - 3,891,150) 2014 Modelled IHME
3,171,000 (2,572,960 - 3,889,800) 2015 Modelled IHME
3,184,310 (2,570,960 - 3,916,200) 2016 Modelled IHME
3,199,580 (2,575,210 - 3,939,860) 2017 Modelled IHME
3,206,500 (2,581,430 - 3,950,000) 2018 Modelled IHME
3,209,770 (2,585,300 - 3,956,410) 2019 Modelled IHME
4,748,000 (3,238,000 - 4,960,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.05 (5.77 - 8.50) 2019 Modelled IHME
7.03 (5.91 - 8.31) 2018 Modelled IHME
7.14 (6.28 - 8.23) 2017 Modelled IHME
7.67 (6.73 - 8.75) 2016 Modelled IHME
7.89 (6.95 - 9.02) 2015 Modelled IHME
7.93 (6.95 - 9.08) 2014 Modelled IHME
7.44 (6.53 - 8.52) 2013 Modelled IHME
7.21 (6.32 - 8.26) 2012 Modelled IHME
7.08 (6.19 - 8.12) 2011 Modelled IHME
7.33 (6.38 - 8.38) 2010 Modelled IHME
6.99 (6.08 - 8.01) 2009 Modelled IHME
7.08 (6.16 - 8.11) 2008 Modelled IHME
6.72 (5.86 - 7.70) 2007 Modelled IHME
6.78 (5.89 - 7.79) 2006 Modelled IHME
7.05 (6.11 - 8.15) 2005 Modelled IHME
6.24 (5.43 - 7.18) 2004 Modelled IHME
5.88 (5.12 - 6.78) 2003 Modelled IHME
5.28 (4.61 - 6.08) 2002 Modelled IHME
4.71 (4.13 - 5.42) 2001 Modelled IHME
4.28 (3.75 - 4.92) 2000 Modelled IHME
3.81 (3.33 - 4.39) 1999 Modelled IHME
3.38 (2.94 - 3.89) 1998 Modelled IHME
3.38 (2.96 - 3.90) 1997 Modelled IHME
3.61 (3.16 - 4.16) 1996 Modelled IHME
3.84 (3.33 - 4.44) 1995 Modelled IHME
3.86 (3.32 - 4.48) 1994 Modelled IHME
3.3 (2.88 - 3.81) 1993 Modelled IHME
2.62 (2.30 - 3.01) 1992 Modelled IHME
2.34 (2.06 - 2.70) 1991 Modelled IHME
2.26 (1.99 - 2.60) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
10,350 (8,469 - 12,467) 2019 Modelled IHME
10,317 (8,666 - 12,189) 2018 Modelled IHME
10,469 (9,197 - 12,065) 2017 Modelled IHME
11,222 (9,857 - 12,815) 2016 Modelled IHME
11,544 (10,159 - 13,196) 2015 Modelled IHME
11,583 (10,146 - 13,256) 2014 Modelled IHME
10,850 (9,518 - 12,430) 2013 Modelled IHME
10,505 (9,206 - 12,030) 2012 Modelled IHME
10,304 (8,995 - 11,807) 2011 Modelled IHME
10,653 (9,276 - 12,189) 2010 Modelled IHME
10,166 (8,844 - 11,643) 2009 Modelled IHME
10,305 (8,971 - 11,801) 2008 Modelled IHME
9,790 (8,536 - 11,228) 2007 Modelled IHME
9,894 (8,601 - 11,383) 2006 Modelled IHME
10,327 (8,948 - 11,939) 2005 Modelled IHME
9,178 (7,987 - 10,569) 2004 Modelled IHME
8,673 (7,557 - 10,004) 2003 Modelled IHME
7,816 (6,834 - 9,006) 2002 Modelled IHME
7,002 (6,142 - 8,048) 2001 Modelled IHME
6,386 (5,592 - 7,342) 2000 Modelled IHME
5,705 (4,975 - 6,574) 1999 Modelled IHME
5,066 (4,414 - 5,833) 1998 Modelled IHME
5,082 (4,441 - 5,858) 1997 Modelled IHME
5,434 (4,750 - 6,260) 1996 Modelled IHME
5,800 (5,032 - 6,697) 1995 Modelled IHME
5,844 (5,017 - 6,772) 1994 Modelled IHME
5,012 (4,364 - 5,786) 1993 Modelled IHME
3,977 (3,491 - 4,570) 1992 Modelled IHME
3,542 (3,120 - 4,085) 1991 Modelled IHME
3,406 (3,008 - 3,925) 1990 Modelled IHME
2,861 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
28 (24 - 32) 2019 Modelled IHME
28 (25 - 32) 2018 Modelled IHME
28 (25 - 32) 2017 Modelled IHME
28 (25 - 31) 2016 Modelled IHME
28 (24 - 31) 2015 Modelled IHME
28 (24 - 31) 2014 Modelled IHME
27 (24 - 31) 2013 Modelled IHME
27 (24 - 30) 2012 Modelled IHME
27 (24 - 30) 2011 Modelled IHME
26 (23 - 30) 2010 Modelled IHME
26 (23 - 30) 2009 Modelled IHME
26 (23 - 29) 2008 Modelled IHME
26 (23 - 30) 2007 Modelled IHME
26 (23 - 29) 2006 Modelled IHME
26 (22 - 29) 2005 Modelled IHME
26 (23 - 29) 2004 Modelled IHME
26 (22 - 29) 2003 Modelled IHME
26 (22 - 29) 2002 Modelled IHME
26 (22 - 29) 2001 Modelled IHME
25 (22 - 29) 2000 Modelled IHME
26 (22 - 29) 1999 Modelled IHME
26 (22 - 29) 1998 Modelled IHME
26 (22 - 29) 1997 Modelled IHME
26 (22 - 29) 1996 Modelled IHME
25 (22 - 29) 1995 Modelled IHME
25 (22 - 29) 1994 Modelled IHME
25 (22 - 29) 1993 Modelled IHME
26 (23 - 30) 1992 Modelled IHME
26 (23 - 30) 1991 Modelled IHME
27 (23 - 30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
2 (1 - 3) 2016 Survey/reported Barska G and Sazanov JA, 2016.
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
HepB birth dose policy
Yes
Year of birth dose introduction
2000
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
7,098
2019
(5,727 - 8,653)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
10,350
2019
(8,469 - 12,467)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
2
2016
(1 - 3)
Barska G and Sazanov JA, 2016.
Eligible for HBV generic medicines
Eligible for HCV generic medicines